Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Liver Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Liver Cancer
    TopAbstracts in Liver Cancer 10/29/2009 - (DGNews)
    Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma - (N Engl J Med)
    TopAbstracts in Liver Cancer 10/15/2009 - (DGNews)
    MicroRNA expression, survival, and response to interferon in liver cancer - (N Engl J Med)
    CD4 Cell Count Key to Predicting Risk of Cancers in Patients With HIV - (DGNews)

    News archive

     Recent webcasts/CME - Liver Cancer
    • Evidence-Based Treatment of Intermediate- to Advanced-Stage Hepatocellular Carcinoma: Improving Outcomes With Modern Therapies
    • Focus on Treatment Options and Clinical Issues in Metastatic Hepatocellular Carcinoma
    • Focus on Treatment Options and Clinical Issues in Locally Advanced Hepatocellular Carcinoma
    • Risk of Hepatocellular Carcinoma in Hepatitis B and Prevention Through Treatment

      Webcasts/CME archive

       Recent cases - Liver Cancer
        Complete Pathological Response in a Patient with Multiple Liver Metastases from Colon Cancer Treated with Folfox-6 Chemotherapy Plus Bevacizumab: A Case Report
        Well-Differentiated Gall Bladder Hepatoid Carcinoma Producing Alpha-Fetoprotein: A Case Report
        A Case of Hepatic Angiomyolipoma Difficult to Distinguish from Hepatocellular Carcinoma
        Hepatocellular Carcinoma and Crohn's Disease: A Case Report and Review
        Primary Hepatic Embryonal Sarcoma Masquerading as Metastatic Ovarian Cancer

        Cases archive
          




        my personal edition > liver cancer > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Intraoperative Ultrasound Better Than CT or PET In Detecting Liver Metastases: Presented at SSO

        By Crystal Phend

        SAN DIEGO, C.A. -- March 27, 2006 -- Intraoperative ultrasound is more accurate than computed tomography (CT), CT angioportogram and positron emission tomography (PET) imaging, according to research presented here at the annual meeting of the Society of Surgical Oncology (SSO).

        "Intraoperative ultrasound still remains the gold standard," said lead author Mehul Patel, MD, medical resident, McLaren Regional Medical Center, Flint, Michigan, United States, in a presentation March 24th.

        Until now, data comparing the three types of imaging in patients with liver cancer were scarce. The issue is important, Dr. Patel said, because percutaneous radiofrequency ablation requires preoperative localization of liver metastases, which does not allow for intraoperative ultrasound. "The efficacy of percutaneous radiofrequency ablation thus may be limited due to its inability to perform intraoperative ultrasound," Dr. Patel said.

        His team conducted a retrospective chart review of 53 patients who underwent surgery to remove liver metastases. The same surgical oncologist treated all patients, and they all had preoperative CT scan. Of these, 24 also received a preoperative PET scan, 39 had intraoperative ultrasound, and 28 had a CT angioportogram.

        Twenty-four had the combination of CT scan, PET scan and intraoperative ultrasound; 21 received the combination of CT angioportogram and intraoperative ultrasound; \13 had CT angioportogram, PET and intraoperative ultrasound.

        Results of the chart review show that intraoperative ultrasound found the most lesions per patient (2.6), followed by CT scan (2.4), CT angioportogram (2.0), and PET scan (1.7).

        When combined, preoperative CT and PET found 2.3 lesions per patient compared with 2.8 with intraoperative ultrasound alone. Intraoperative imaging found additional lesions in 33%, fewer lesions in 17%, and the same number of lesions in 50% compared to preoperative imaging.

        The combination of CT angioportogram and PET found the same 2.4 lesions per patient as intraoperative ultrasound. Intraoperative imaging found more lesions than this preoperative combination in 15.4% of patients and fewer lesions in another 15.4%.

        Dr. Patel and his colleagues concluded that intraoperative ultrasound was more effective than any single preoperative imaging method and is thus more cost effective.


        [Presentation title: Comparative Analysis of CT-scan, CT Angioportogram and PET-scan with Intraoperative Ultrasound in Detecting Liver Metastases. Poster 70]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send